GENETAC Trademark

Trademark Overview


On Monday, October 19, 2020, a trademark application was filed for GENETAC with the United States Patent and Trademark Office. The USPTO has given the GENETAC trademark a serial number of 90263391. The federal status of this trademark filing is SU - REGISTRATION REVIEW COMPLETE as of Monday, November 18, 2024. This trademark is owned by Design Therapeutics, Inc.. The GENETAC trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

pharmaceutical preparations for the treatment of degenerative disorders and diseases, genetic disorders and diseases, and disorders and diseases caused by transcriptional dysregulation; therapeutic pharmaceuticals for the treatment of degenerative disorders and diseases, genetic disorders and diseases, and disorders and diseases caused by transcriptional dysregulation; small molecule therapies for the treatment of degenerative disorders and diseases, genetic disorders and diseases, and disorders and diseases caused by transcriptional dysregulation, all of the foregoing related to therapies that target nucleic acids and modulate gene expression

pharmaceutical research and products development for the treatment of degenerative disorders and diseases, genetic disorders and diseases, and disorders and diseases caused by transcriptional dysregulation; research and development of therapeutics for the treatment of degenerative disorders and diseases, genetic disorders and diseases, and disorders and diseases caused by transcriptional dysregulation; research and development in the field of small molecule therapeutics; scientific research for medical purposes in the field of degenerative disorders and diseases, genetic disorders and diseases, and disorders and diseases caused by transcriptional dysregulation; medical and scientific research in the field of pharmaceuticals, all of the foregoing related to therapies that target nucleic acids and modulate gene expression

General Information


Serial Number90263391
Word MarkGENETAC
Filing DateMonday, October 19, 2020
Status819 - SU - REGISTRATION REVIEW COMPLETE
Status DateMonday, November 18, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 4, 2021

Trademark Statements


Goods and Servicespharmaceutical preparations for the treatment of degenerative disorders and diseases, genetic disorders and diseases, and disorders and diseases caused by transcriptional dysregulation; therapeutic pharmaceuticals for the treatment of degenerative disorders and diseases, genetic disorders and diseases, and disorders and diseases caused by transcriptional dysregulation; small molecule therapies for the treatment of degenerative disorders and diseases, genetic disorders and diseases, and disorders and diseases caused by transcriptional dysregulation, all of the foregoing related to therapies that target nucleic acids and modulate gene expression
Pseudo MarkGENETIC
Goods and Servicespharmaceutical research and products development for the treatment of degenerative disorders and diseases, genetic disorders and diseases, and disorders and diseases caused by transcriptional dysregulation; research and development of therapeutics for the treatment of degenerative disorders and diseases, genetic disorders and diseases, and disorders and diseases caused by transcriptional dysregulation; research and development in the field of small molecule therapeutics; scientific research for medical purposes in the field of degenerative disorders and diseases, genetic disorders and diseases, and disorders and diseases caused by transcriptional dysregulation; medical and scientific research in the field of pharmaceuticals, all of the foregoing related to therapies that target nucleic acids and modulate gene expression

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, December 7, 2020
Primary Code005
First Use Anywhere DateMonday, August 5, 2024
First Use In Commerce DateMonday, August 5, 2024

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, December 7, 2020
Primary Code042
First Use Anywhere DateTuesday, August 6, 2024
First Use In Commerce DateTuesday, August 6, 2024

Trademark Owner History


Party NameDesign Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCarlsbad, CA 92011

Party NameDesign Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCarlsbad, CA 92011

Trademark Events


Event DateEvent Description
Monday, March 29, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, October 22, 2020NEW APPLICATION ENTERED
Monday, December 7, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, March 18, 2021ASSIGNED TO EXAMINER
Wednesday, April 14, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 4, 2021PUBLISHED FOR OPPOSITION
Tuesday, May 4, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, May 20, 2021EXTENSION OF TIME TO OPPOSE RECEIVED
Thursday, October 28, 2021OPPOSITION INSTITUTED NO. 999999
Monday, March 20, 2023OPPOSITION TERMINATED NO. 999999
Monday, March 20, 2023OPPOSITION DISMISSED NO. 999999
Monday, March 20, 2023TTAB RELEASE CASE TO TRADEMARKS
Tuesday, May 2, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, July 21, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, July 21, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, July 21, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, July 21, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, July 21, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, October 20, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, October 24, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 29, 2024SOU TEAS EXTENSION RECEIVED
Friday, October 20, 2023SOU EXTENSION 1 FILED
Friday, October 20, 2023SOU EXTENSION 1 GRANTED
Monday, April 29, 2024SOU EXTENSION 2 FILED
Monday, April 29, 2024SOU EXTENSION 2 GRANTED
Tuesday, April 30, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 10, 2024TEAS STATEMENT OF USE RECEIVED
Tuesday, November 12, 2024STATEMENT OF USE PROCESSING COMPLETE
Monday, November 18, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, November 18, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, September 10, 2024USE AMENDMENT FILED
Tuesday, November 12, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL